Sangamo Therapeutics (SGMO) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q3 EPS of ($0.59), $0.27 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.39 million versus the consensus estimate of $9.36 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
